Main Clinical Data of 25 Patients Classified by Their Lupus Anticoagulants
| . | Antiprothrombin Antibodies (n = 14) . | Anticardiolipin Antibodies (n = 11) . | P . |
|---|---|---|---|
| Sex, M/F | 2/12 | 6/5 | NS |
| Age (yr), median | 42 | 39 | NS |
| Autoimmune diseases | 1 (7%) | 0 | NS |
| Neoplastic diseases | 1 (7%) | 1 (9%) | NS |
| Thrombocytopenia | 5 (36%) | 3 (27%) | NS |
| Recurrent miscarriages (≥2) | 0 | 1 (20%) | NS |
| History of venous and/or arterial thrombosis | 3 (21%) | 8 (73%) | .03 |
| . | Antiprothrombin Antibodies (n = 14) . | Anticardiolipin Antibodies (n = 11) . | P . |
|---|---|---|---|
| Sex, M/F | 2/12 | 6/5 | NS |
| Age (yr), median | 42 | 39 | NS |
| Autoimmune diseases | 1 (7%) | 0 | NS |
| Neoplastic diseases | 1 (7%) | 1 (9%) | NS |
| Thrombocytopenia | 5 (36%) | 3 (27%) | NS |
| Recurrent miscarriages (≥2) | 0 | 1 (20%) | NS |
| History of venous and/or arterial thrombosis | 3 (21%) | 8 (73%) | .03 |
Abbreviation: NS, not significant.
Data from Galli et al.52